Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-07-010209
Filing Date
2007-12-14
Accepted
2007-12-14 15:36:30
Documents
1
Period of Report
2007-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 11097
  Complete submission text file 0001005477-07-010209.txt   12967
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORP 41 SEYON ST. BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 7812500111
HERLIHY WALTER C (Reporting) CIK: 0001241029 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 071307274